SKP-104, A NOVEL MODIFIED-RELEASE FORMULATION OF ZALEPLON, SIGNIFICANTLY IMPROVES SLEEP IN PATIENTS WITH MIDDLE-OF-THENIGHT AWAKENING: RESULTS OF A PHASE II, DOUBLE-BLIND, CROSSOVER, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL
- Resource Type
- Abstract
- Source
- In
Sleep Medicine 2011 12 Supplement 1:S7-S7 - Subject
Abstracts - Language
- ISSN
- 1389-9457